Alpha 2.0
Login Register
» Articles » PMID: 32696029

Re: Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or Without Chemotherapy

Overview
Journal Facts Views Vis Obgyn
Specialty Gynecology & Obstetrics
Date 2020 Jul 23
PMID 32696029
Authors
Luz Angela Torres-de la Roche
Rudy Leon De Wilde
Affiliations
Soon will be listed here.
References
1.
Grabenbauer G, Girke P, Wildt L, Muller R, Herbst M, Sauer R . [Ovariopexy and the treatment of Hodgkin's disease]. Strahlenther Onkol. 1991; 167(5):273-6. View
2.
von Wolff M, Kammerer U, Kollmann Z, Santi A, Dietl J, Frambach T . Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but does not completely prevent a follicle-stimulating hormone flare-up. Fertil Steril. 2010; 95(1):452-4. DOI: 10.1016/j.fertnstert.2010.08.053. View
3.
Turkgeldi L, Cutner A, Turkgeldi E, Al Chami A, Cassoni A, Macdonald N . Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy. Facts Views Vis Obgyn. 2020; 11(3):235-242. PMC: 7020947. View
4.
De Wilde R, Hesseling M . No more radiogenic castration in women with Hodgkin's disease?. Am J Obstet Gynecol. 1995; 173(5):1639. DOI: 10.1016/0002-9378(95)90674-6. View